← Back to Search

Other

CSJ117 for Asthma

Phase 2
Waitlist Available
Research Sponsored by Novartis Pharmaceuticals
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 2, 6 and 12 weeks

Summary

This trial is testing a new inhaled medication called CSJ117 to help people with COPD who still have symptoms despite using standard treatments. The medication aims to reduce lung inflammation and improve breathing.

Eligible Conditions
  • Asthma
  • Chronic Obstructive Pulmonary Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 2, 6 and 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 2, 6 and 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change from baseline in E-RS score
Secondary study objectives
Accumulation ratio (Racc) of CSJ117
Change from baseline in CAT score
Change from baseline in SGRQ-C score
+11 more

Trial Design

3Treatment groups
Experimental Treatment
Placebo Group
Group I: CSJ117 8mgExperimental Treatment1 Intervention
Intervention: Drug: CSJ117
Group II: CSJ117 4mgExperimental Treatment1 Intervention
Intervention: Drug: CSJ117
Group III: CSJ117 PlaceboPlacebo Group1 Intervention
Intervention: Drug: Placebo
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CSJ117
2021
Completed Phase 2
~70

Find a Location

Who is running the clinical trial?

Novartis PharmaceuticalsLead Sponsor
2,911 Previous Clinical Trials
4,250,638 Total Patients Enrolled
80 Trials studying Asthma
46,022 Patients Enrolled for Asthma
~9 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top